Third dose of Pfizer / BioNTech COVID vaccine gives better effect than first two
Pfizer will announce the need for a third dose of the coronavirus vaccine on July 12, The Washington Post reported.
Pharmaceutical company Pfizer intends to notify US government officials about the need for a third dose of the coronavirus vaccine to achieve stronger immunity. It is reported by The Washington Post with reference to six interlocutors familiarized with the company’s plans.
As the newspaper writes, Pfizer plans to hold a briefing on Monday, July 12, to which American officials were invited, in particular, the chief adviser to the President of the United States on medical issues, director of the National Institute of Allergic and Infectious Diseases Anthony Fauci.
Pfizer says the results of the study showed that a booster dose of their vaccine, given six months after the second shot, increased the antibody count by 5-10 times over the first two injections, writes WP.
Pfizer also announced that it will begin testing a booster dose in August to combat the Delta strain of coronavirus, which is believed to be more infectious.
We will remind, in May in Britain started the first in the world third dose efficacy study vaccines against coronavirus. It was planned to vaccinate each volunteer with a third dose of one of seven COVID vaccines registered and unregistered in the country.
News from Correspondent.net in Telegram. Subscribe to our channel https://t.me/korrespondentnet